Case Study: PAREXEL achieves flexible working capital to meet DSO targets with C2FO

PAREXEL - Customer Case Study

PAREXEL International, a $2B multinational life sciences consulting firm that conducts clinical trials, faced strategic cash-flow challenges such as meeting internal DSO targets, funding acquisitions, and preserving debt capacity. To address these needs, PAREXEL turned to C2FO and its working capital program, using C2FO account reps/working capital advisors as consultants to manage timing and cash requirements.

C2FO implemented a flexible early-pay discounting solution that lets PAREXEL choose the discount rate, timing, and amount with no signing agreements, fixed rates, or long-term commitment. As a result, C2FO-generated cash helps PAREXEL hit quarterly DSO targets, provide working capital for acquisitions, and maintain desired debt capacity, with the program run on a quarterly cadence.

PAREXEL

Sekar Sundaram

Director, Treasury